Ryan Crow
Senior Vice President, Investor Relations
Replay available
Regeneron Pharmaceuticals, Inc. (REGN) Q1 2025 Earnings Call
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q1 2025 earnings conference call, held 2025-04-29. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Leonard Schleifer
President and Chief Executive Officer
Dr. George Yancopoulos
Chief Scientific Officer
Marion McCourt
Executive Vice President, Commercial
Chris Fenimore
Executive Vice President and Chief Financial Officer
Tyler Van Buren
Analyst, TD Cowan
Alexandria Hammond
Analyst, Wolf Research
Chris Shaw
Analyst, JP Morgan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Regeneron Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.280 Welcome to the Regeneron Pharmaceuticals First Quarter 2025 Earnings Conference 00:00:05.280 -- 00:00:09.166 Call. My name is Josh, and I will be your operator for today's call. 00:00:09.166 -- 00:00:12.331 At this time, all participants are in a listen-only mode. 00:00:12.331 -- 00:00:15.416 Later, we will conduct a question-and-answer session. 00:00:15.416 -- 00:00:18.120 Please note that this conference call is being recorded. 00:00:18.120 -- 00:00:23.169 I will now turn the call over to Ryan Crow, Senior Vice President, Investor 00:00:23.169 -- 00:00:24.571 Relations. You may begin. 00:00:24.571 -- 00:00:26.571 Thank 00:00:26.594 -- 00:00:30.418 you, Josh. Good morning, good afternoon, and good evening to everyone listening around 00:00:30.418 -- 00:00:34.324 the world. Thank you for your interest in Regeneron, and welcome to our first quarter 00:00:34.324 -- 00:00:39.593 2025 earnings conference call. An archive and transcript of this call will be available 00:00:39.593 -- 00:00:45.402 on Regeneron's investor relations website shortly after the call ends. 00:00:45.402 -- 00:00:50.470 Joining me on today's call are Dr. Leonard Schleifer, board co-chair, co-founder, 00:00:50.470 -- 00:00:54.736 president, and chief executive officer. Dr. 00:00:54.736 -- 00:00:59.946 George Yancopoulos, Board Co-Chair, Co-Founder, President and Chief Scientific 00:00:59.946 -- 00:01:05.557 Officer, Marion McCourt, Executive Vice President of Commercial, 00:01:05.557 -- 00:01:11.966 and Chris Fenimore, Executive Vice President and Chief Financial Officer. 00:01:12.250 -- 00:01:17.352 After our prepared remarks, the remaining time will be available for Q&A. 00:01:17.352 -- 00:01:21.376 I would like to remind you that remarks made on today's call ma...